Common Stock, Shares, Outstanding of Immunovant, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Immunovant, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Immunovant, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 203,316,885, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Immunovant, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 203,316,885 +56,113,320 +38% 31 Dec 2025 10-Q 06 Feb 2026 2026 Q3
Q3 2025 174,532,710 +27,967,661 +19% 30 Sep 2025 10-Q 10 Nov 2025 2026 Q2
Q2 2025 171,069,176 +24,873,503 +17% 30 Jun 2025 10-Q 11 Aug 2025 2026 Q1
Q1 2025 170,111,593 +24,528,594 +17% 31 Mar 2025 10-Q 06 Feb 2026 2026 Q3
Q4 2024 147,203,565 +2,109,513 +1.5% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q3
Q3 2024 146,565,049 +15,123,025 +12% 30 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 146,195,673 +15,630,244 +12% 30 Jun 2024 10-Q 06 Aug 2024 2025 Q1
Q1 2024 145,582,999 +15,253,136 +12% 31 Mar 2024 10-K 29 May 2025 2025 FY
Q4 2023 145,094,052 +15,833,798 +12% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q3
Q3 2023 131,442,024 +14,827,936 +13% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 130,565,429 +14,041,271 +12% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 130,329,863 +13,846,964 +12% 31 Mar 2023 10-K 29 May 2024 2024 FY
Q4 2022 129,260,254 +14,150,421 +12% 31 Dec 2022 10-Q 03 Feb 2023 2023 Q3
Q3 2022 116,614,088 +1,615,217 +1.4% 30 Sep 2022 10-Q 04 Nov 2022 2023 Q2
Q2 2022 116,524,158 +18,546,563 +19% 30 Jun 2022 10-Q 05 Aug 2022 2023 Q1
Q1 2022 116,482,899 +18,511,656 +19% 31 Mar 2022 10-K 22 May 2023 2023 FY
Q4 2021 115,109,833 +17,138,590 +17% 31 Dec 2021 10-Q 04 Feb 2022 2022 Q3
Q3 2021 114,998,871 +17,108,166 +17% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q2
Q2 2021 97,977,595 +17,065,868 +21% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q1
Q1 2021 97,971,243 +43,315,867 +79% 31 Mar 2021 10-K 08 Jun 2022 2022 FY
Q4 2020 97,971,243 +43,315,867 +79% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 97,890,705 +94,358,157 +2671% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 80,911,727 +77,366,670 +2182% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q1
Q1 2020 54,655,376 +16,064,995 +42% 31 Mar 2020 10-K 01 Jun 2021 2020 FY
Q4 2019 54,655,376 +51,780,376 +1801% 31 Dec 2019 10-Q 14 Feb 2020 2019 Q3
Q3 2019 3,532,548 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 3,545,057 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 38,590,381 31 Mar 2019 10-K 29 Jun 2020 2019 FY
Q4 2018 2,875,000 31 Dec 2018 10-Q 13 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.